news HIV epidemic on track to be controlled by 2020By Dr Zara Kassam (European Pharmaceutical Review)
news Pembrolizumab shows promise in pretreated metastatic gastric cancerBy Dr Zara Kassam (European Pharmaceutical Review)
news FDA approves Mylotarg for treatment of acute myeloid leukemiaBy Dr Zara Kassam (European Pharmaceutical Review)
news Anacetrapib reduces risk of serious cardiovascular eventsBy Dr Zara Kassam (European Pharmaceutical Review)
news Venture launched for a novel compound against malariaBy Dr Zara Kassam (European Pharmaceutical Review)
news Experimental treatment for Niemann-Pick disease appears safeBy Dr Zara Kassam (European Pharmaceutical Review)
news Drugs taken before surgery may reduce metastatic recurrenceBy Dr Zara Kassam (European Pharmaceutical Review)
news US ophthalmic drugs market set to pass $34bn by 2025By Dr Zara Kassam (European Pharmaceutical Review)
news UK trails behind EU in cancer diagnosis & treatmentBy Niamh Marriott (European Pharmaceutical Review)
article Life sciences moves to unify clinical operations to improve study qualityBy Rik Van Mol | Vice President of R&D Strategy Europe | Veeva Systems
news NICE approves 3 drugs for treating plaque psoriasis in childrenBy Niamh Marriott (European Pharmaceutical Review)
news Study examines link between marijuana and vulnerability to psychosisBy Niamh Marriott (European Pharmaceutical Review)
news NICE recommends cabozantinib for advanced renal cell cancerBy Niamh Marriott (European Pharmaceutical Review)
news Mindfulness-based therapy may reduce stress in obese patientsBy Niamh Marriott (European Pharmaceutical Review)
Follow: